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I. X-RAY CRYSTAL STRUCTURE DETERMINATION
Diffraction experiments were performed on a Gemini S diffractometer (Oxford Diffraction) equipped with a Sapphire 3 CCD detector. A sealed tube with the Mo-target anode and graphite monochromator was used as the source of X-radiation (Mo Kα, λ = 0.71073 Å). Data were collected with the ω-scan technique at room temperature. The reflection intensities were integrated and corrected for background, Lorentz-polarization effect and absorption with the CrysAlisPRO 1 .
Structures were solved by SIR92 2 or SHELXT 3 . All structures were refined with the SHELXL 4 by full-matrix least-squares procedure based on F 2 . The SHELXLE 5 was used as a graphical user interface. All non-hydrogen atoms were refined anisotropically. Hydrogen atoms connected to carbon atoms were introduced in idealized positions and refined using riding model. Hydrogen atoms bonded to oxygen atoms were found in difference Fourier maps and refined isotropically, while is some cases distance restraints d(O-H) = 0.82(2) Å and ADP constraints U iso (H) = 1.2U eq (O) were applied (see CIF data for details). Absolute structures of all compounds were determined by reference to the stereocenters of know chirality (unchanged during synthetic procedure). The Flack parameters were meaningless, due to weak anomalous scattering power of the compounds. Pertinent crystallographic and refinement data are listed in Table S1 .
Crystallographic data reported in this paper have been deposited at the Cambridge Crystallographic The structure-activity relationships were accessed as follows: the IC 50 values of two compounds were compared, and the ∆ log IC 50 was calculated (∆ log IC 50 is a difference between the log IC 50 values of an analogue and the corresponding control compound). Positive ∆ log IC 50 values show a decrease of antiproliferative activity, whereas negative values indicate an increase in the activity upon the structural modification being considered. The results are presented in Figure S7 . S7 S8 Figure S7 . Contributions of selected structural features to the antiproliferative activities. The influence of OH → OMe replacement. Figure S8 . Percents of specific apoptosis and necrosis induced with compounds 1, 3, 4, 5, 9 and 10. Figure S9 . Percents of specific apoptosis and necrosis induced with compounds 2, 6, 7 and 8. Figure S10 . Influence of compounds 1, 3, 4, 5, 9 and 10 on the K562 cell cycle. 
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